Wire · opportunities
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 September 2026 · Fusion42 review
Pattern Bioscience received FDA Breakthrough Device Designation for its Urine ID/AST Panel, a rapid diagnostic assay aimed at speeding the detection and antibiotic susceptibility testing of urinary tract infections directly from specimens.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You need to prepare for faster competition as direct-from-specimen infection diagnostics gain priority. This FDA designation signals a shift where rapid turnaround in clinical labs becomes a baseline expectation, pressuring slower culture-dependent testing providers.
◆ Coverage
3 sources · 21 Sep 2026
◆ Related on Wire
◆ Topics